Keratin 9 gene mutations in five Korean families with epidermolytic palmoplantar keratoderma

Experimental Dermatology

Volumn 12, Issue 6, 2003, Pages 876-881

  Lee, Joo Heung ^a   Ahn, Kwang Sung ^b   Lee, Cha Hui ^b   Youn, Seong Jae ^a   Kim, Jong Wook ^c   Lee, Dong Youn ^a   Lee, Eil Soo ^a   Steinert, Peter M ^d   Yang, Jun Mo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Inha University School of Medicine   (South Korea)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Epidermolytic palmoplantar keratoderma; Keratin 9 gene; Mutations

Indexed keywords

AMINO ACID; DIMER; INTERMEDIATE FILAMENT PROTEIN; KERATIN; KERATIN 9; TETRAMER; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIMERIZATION; EPIDERMOLYTIC PALMOPLANTAR KERATODERMA; FAMILY STUDY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CODE; HUMAN; HUMAN TISSUE; KERATODERMA; KOREA; MALE; PREDICTION; PROTEIN DOMAIN; PROTEIN STRUCTURE; SCHOOL CHILD; STRUCTURE ANALYSIS;

ADOLESCENT; ADULT; CHILD; DIMERIZATION; DNA; FAMILY HEALTH; FEMALE; HUMANS; HYPERKERATOSIS, EPIDERMOLYTIC; KERATINS; KERATODERMA, PALMOPLANTAR; KOREA; MALE; MUTATION; PEDIGREE; PEPTIDES; PROTEIN STRUCTURE, TERTIARY;

EID: 0346969814     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2003.00012.x     Document Type: Article

References (24)

1. Stevens H P, Leigh I M, Eisen A Z, et al, eds. Dermatology in General Medicine. New York: McGraw-Hill, 1999: 603-613.
2. Voerner H. Zur Kenntnis des keratoma hereditarium palmare et plantare. Arch Derm Syph 1901: 56: 3-31.
3. Reis A, Hennies H-C, Langbein L, et al. Keratin 9 gene mutations in epidermolytic palmoplantar keratoderma (EPPK). Nature Genet 1994: 6: 174-179.
4. Johnson B Jr, Honig P. Congenital diseases (Genodermatoses). In: Elder D, Elenitsas R, Jaworsky C, Johnson B JR, eds. Histopathology of the Skin. Philadelphia: Lippincott-Raven, 1997: 117-150.
5. Kelsell D P, Stevens H P. The palmoplantar keratodermas. Much more than palms and soles. Mol Med Today 1999, 107-113.
6. Lane D B. Keratins. In: Royce P M, Steinmann B, eds. Connective Tissue and Its Heritable Disorders: Molecular, Genetic and Medical Aspects. New York: Wiley-Liss, 1993: 237-247.
7. Moll R, Franke W W, Schiller D L, Geiger B, Krepler R. The catalog of human cytokeratins: Patterns of expression in normal epithelial, tumors and cultured cell. Cell 1982: 31: 11-24.
8. Knapp A C, Franke W W, Heide H, Hatzfeld M, Jorcano J L, Moll R. Cytokeratin, 9, and epidermal type I keratin characteristic of a special program of keratinocyte differentiation displaying body site specificity. J Cell Biol 1986: 103: 657-667.
9. Yang J-M, Lee S, Kang H-J, et al. Mutations in the 1A rod domain segment of the keratin 9 gene in epiermolytic palmoplantar keratoderma. Acta Derm Vernereol (Stockh) 1998: 78: 412-416.
10. Sambrook E G, Fritsch E F, Maniatis T. Molecular Cloning: A Laboratory Handbook, 2nd edn. New York: Cold Spring Harbor Laboratory, 1989.
11. Yang J-M, Chipev C C, DiGiovanna J J, et al. Mutation in the H1 and 1A domains in the keratin 1 gene in epidermolytic hyperkeratosis. J Invest Dermatol 1994: 102: 17-23.
12. Chipev C C, Korge B P, Markova N, et al. A leucine to proline mutation in the H1 subdomain of keratin 1 causes epidermolytic hyperkeratosis. Cell 1992: 70: 821-828.
13. Steinert P M, Yang J-M, Bale S J, Compton J G. Concurrence between the molecular overlap regions in keratin intermediate filaments and the location of keratin mutations in genodermatoses. Biochem Biophys Res Commun 1993: 197: 840-848.
14. 11 alignment mode in keratin intermediate filaments. J Biol Chem 2001: 276: 2088-2097.
15. Fuchs E. Genetic disorders of keratins and their associated proteins. J Dermatol Sci 1996: 13: 181-192.
16. Corden L D, McLean Wh I. Human keratin disease: Hereditary fragility of specific epithelial tissues. Exp Dermatol 1996: 5: 297-307.
17. Torchard D, Blanchet-Bardon C, Serova O, et al. Epidermolytic palmoplantar keratoderma cosegregates with a keratin 9 mutation in a pedigree with breast and ovarian cancer. Nature Genet 1994: 6: 106-109.
18. Hennies H-C, Zehender D, Kunze J, Kuester W, Reis A. Keratin 9 gene mutational heterogeneity in patients with epidermolytic palmoplantar keratoderma. Hum Genet 1994: 93: 649-654.
19. Bonifas J M, Matsumura K, Chen M A, et al. Mutations of keratin 9 in two families with palmoplantar epidermolytic hyperkeratosis. J Invest Dermatol 1994: 103: 474-477.
20. Navsaria H A, Swensson O, Ratnavel R C, et al. Ultrastructural changes resulting from keratin-9 gene mutations in two families with epidermolytic palmoplantar keratoderma. J Invest Dermatol 1995: 104: 425-429.
21. Endo H, Hatamochi A, Shinkai H. A novel mutation of a leucine residue in coil 1A of keratin 9 in epidermolytic palmoplantar keratoderma. J Invest Dermatol 1997: 109: 113-115.
22. Coleman C M, Munro C S, Smith F J D, Uitto J, McLean Wh I. Epidermolytic palmoplantar keratoderma due to a novel type of mutation, a 3-bp insertion in the keratin 9 helix termination motif. Br J Dermatol 1999: 140: 486-490.
23. Steinert P M, Marekov L N, Fraser R D B, Parry D A D. Keratin intermediate filament structure. Crosslinking studies yield quantitative information on molecular dimension and mechanism of assembly. J Mol Biol 1993: 230: 436-452.
24. Strelkov S V, Herrmann H, Geisler N, et al. Conserved segments 1A and 2B of the intermediate filament dimer: Their atomic structure and role in filament assembly. EMBO J 2002: 21: 1255-1266.